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Abstract
Background: As it is uncertain whether psychological treatments for depressive symptoms are effective in elderly
inpatients with significant medical comorbidity, we aimed to assess the treatment effectiveness not only on
depressive symptoms but also on somatic symptoms in these inpatients.
Methods: We performed a meta-analysis of randomized controlled studies assessing the effects of psychological
treatments in Chinese older inpatients with significant medical comorbidity based upon extensive searches of the
most comprehensive computerized Chinese academic database.
Results: The overall effect size for depressive symptoms of twelve studies which compared psychological
treatments with a care-as-usual control group was d = 0.80 (95% Confidence Intervals (CI) = 0.60-0.99; p < 0.001).
The relative risk of psychological intervention of being effective or not, compared to control condition, was 1.52
(95% CI = 1.25-1.85; p < 0.001).
Conclusions: We conclude that psychological treatments of depressive symptoms are effective for Chinese elderly
inpatients with significant medical comorbidity which should receive more attention in medical settings.
Background
Depression is a common mood disorder that can lead to
considerable suffering by patients and their relatives,
physical, cognitive and social dysfunction, a significantly
increased mortality rate and a massive economic burden
[1-3]. It is well acknowledged that the prevalence of
depression in late life is high with major depression ran-
ging from 1% to 5%, and clinically significant depressive
symptoms varying between 8.3% and 15% [4,5], while it
is even higher in older inpatients with significant medi-
cal comorbidity [6]. The prevalence of major depression
among older inpatients with significant medical comor-
bidity ranges from 10% to 25%, and for clinically signifi-
cant depressive symptoms from 23% to 28% [7,8]. In old
age, depression is particularly prevalent in patients with
cardiovascular disease [9], stroke [10], Parkinson’sd i s -
ease [11], diabetes [12], and Alzheimer disease [13]. It is
also widely acknowledged that significant medical
comorbidity may interact with depression [9,14]. On the
one hand, depression in elderly inpatients often ampli-
fies their physical symptoms, impairs their ability to
adhere to medication, and causes higher levels of mor-
bidity and disability [7,15]. On the other hand, there is
considerable evidence that significant medical comorbid-
ity can produce a depressive reaction [14,16].
In a similar way to many Western countries, depres-
sion also results in a great deal of negative effects in
China. Specifically, the cost of treatment for depression
in China was estimated to be approximately 1.0% of the
total national health care costs in 2002 (US$ 814 million
out of US$ 82,385 million) [17]. In consideration of the
rapid growth of the elderly population and the high pre-
valence of depression in older adults that the rates of
major depression and clinically significant depressive
symptoms are 3.82% and 8.8%, respectively in China
[18,19], the cost used for treatment of late life depres-
sion could be enormous, which may include the health
care cost used for elderly inpatients with significant
medical comorbidity.
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therapies are effective in treating depression in the general
elderly population [20,21], but it is not yet clear whether
psychological treatments are effective in older depressed
inpatients with significant medical comorbidity. Because
older depressed inpatients with serious medical comorbid-
ity may show lower response to psychological treatment
for depression, and their depressive symptoms may be due
to physical changes [22], all these make it more difficult to
treat their depression. Furthermore, although there is sub-
stantial evidence that significant medical comorbidity may
interact with depression, it is not known whether psycho-
logical treatments for depression also have positive effects
on medical comorbidity, which has not been explored by
meta-analysis yet.
Taking into consideration the fact that depression in
elderly inpatients with significant medical comorbidity
could cause a great deal of negative effects, a lot of stu-
dies using psychotherapies originated in Western coun-
tries (such as cognitive behavior therapy and non-
directive supportive therapy) have occurred in China
recently. However these studies and the journals they
were published in are local, they are usually not easily
accessed by Western researchers. As a result, it is not
well known whether the psychotherapies widely used in
Western countries are also efficacious for this special
population in this field. However, it is important from a
clinical point of view, because this would indicate that
these psychotherapies have a clinical meaning in non-
Western societies as well. Meanwhile, it is also interest-
ing from a scientific point of view, because if these psy-
chotherapies are effective this implies that they are not
only linked with Western customs and habits, but can
have a broader meaning.
Therefore, we decided to conduct a meta-analysis to
focus exclusively on the effectiveness of psychological
treatments for Chinese elderly inpatients with significant
medical comorbidity. First, we examined whether psy-
chological treatment of depression was effective in redu-
cing the level of depression. Second, we examined
whether psychological treatment of depression was
effective in mitigating the somatic symptoms.
Method
Selection of studies
Studies were selected through a systematic search of a
computerized database of the literature (China National
Knowledge Infrastructure; CNKI) which is the most
comprehensive Chinese academic database. We used
‘elderly or old age or aged’, ‘depression or depressive
symptoms’ and ‘psychological treatment or psychological
intervention or psychotherapy’ as search themes in the
titles, keywords or article abstracts. The search was con-
ducted from 1964 to the end of 2008.
Inclusion and exclusion criteria
We included all studies in which: (1) the subjects were
aged 60 or older; (2) the subjects were inpatients with
significant medical comorbidity; (3) the subjects had a
depressive disorder according to clinical diagnosis as
described in DSM or Clinical diagnosis according to the
Chinese Classification of Mental Disorders (CCMD), or
the mean depression scores (measured with Self-rating
Depression Scale or Symptom Checklist 90-Depression)
of both experimental and control groups were signifi-
cantly higher than the norms of Chinese elderly or above
the cutoff value widely accepted by Chinese practitioners
in this field; (4) the subjects from both experimental and
control groups did not use antidepressant medication; (5)
a psychological treatment was compared to a control
group; (6) a randomized controlled trial was conducted.
We excluded studies on subjects below 60 years of age.
Also excluded were studies in which the depressed inpa-
tients did not have medical comorbidity; studies in which
the effects of the psychological treatment could not be
distinguished from the total intervention and studies in
which insufficient data were available to calculate effect
sizes. Eligibility judgment and data extraction were car-
ried out independently by two researchers. All disparities
between them were resolved by consensus.
Quality assessment
Although many scales are available to assess the validity
and quality of trials, none can provide an adequately
reliable assessment. Therefore, we selected a number of
basic criteria for assessing the validity of the studies, as
suggested by the Cochrane Handbook [23], which are
frequently used in meta-analysis of psychological treat-
ments for depression [20]. There are four basic criteria
in the Cochrane Handbook: allocation to conditions by
an independent (third) party; blinding of assessors of
outcomes; adequacy of random allocation concealment
to respondents and completeness of follow-up data.
Because it was impossible for psychological treatment
studies to conceal random allocation to subjects ade-
quately, we did not use the third basic criteria in the
present study. The assessment was conducted by two
independent reviewers and all disparities between them
were resolved by consensus.
Meta-analyses
We computed the effect size d for each study by sub-
tracting the average post-test score of the control group
(Mc)f r o mt h a to ft h ee x p e r i m e n t a lg r o u p( M e)a n d
dividing the result by the pooled standard deviations of
the experimental and control groups (SDec). or example,
an effect size of 1.0 would indicate a relatively stronger
improvement in treatment by one standard deviation
larger than the mean of the control group. To interpret
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criteria [24]. Effect sizes of 0.80 are regarded as large,
while effect sizes of 0.50 are moderate, and effect sizes
of 0.2 are small. When means and standard deviations
of the studies were not provided, we used other statistics
(c
2 value and p value) to compute effect sizes with the
help of Comprehensive Meta-Analysis (CMA; version
2.2.046). Pooled effect sizes and 95% confidence inter-
vals (CI) were calculated according to the procedures
implemented in CMA.
As considerable heterogeneity was found among these
studies, we decided to calculate mean effect sizes with
the random effects model. As indicators of heterogeneity,
we computed the Q statistic and I
2. I
2 denotes the var-
iance among studies as a proportion of the total variance.
The larger the value of I
2 is, the greater the heterogeneity.
An I
2 of 0% shows no observed heterogeneity, while 25%
shows low, 50% moderate, and 75% high levels of hetero-
geneity [25]. We also computed the Q statistic and
reported whether it was significant or not. If the p value
is above 0.05, it indicates that there is no significant het-
erogeneity and that the total variance results from the
variance within studies rather than from the variance
between studies.
Finally, publication bias of the included studies was
examined by visual inspection of the funnel plot on the
primary outcome measure, and by Duval and Tweedie’s
trim and fill procedure, which provides an estimate of
the effect sizes after publication bias has been consid-
ered (as implemented in CMA).
Results
Study selection
A flowchart describing the inclusion process is pre-
sented in Figure 1. We identified a total of 525 possibly
eligible papers. The titles and abstracts of these 525
papers were studied and 121 were selected for further
examination. Based on the full text of these 121 papers
we finally selected 13 studies for the present meta-analy-
sis [26-38]. The most important reasons for exclusion
were: not being a randomized controlled trial (n = 33),
the patients used antidepressant medications (n = 26),
and the effects of the psychological treatment could not
be distinguished from the total intervention (n = 25).
Other reasons included that the patients were not inpa-
tients or without significant medical comorbidity.
Description of studies
Of the thirteen included studies five were conducted
among inpatients with cardiovascular disease, three
among inpatients with stroke, two among inpatients
with prostatic hyperplasia, one among inpatients with
diabetes mellitus, one among inpatients with leukemia,
and one among inpatients with unspecified medical
comorbidity (Figure 1). In all of these cases, the signifi-
cant medical comorbidities were confirmed by the phy-
sicians on the basis of physic a le x a m i n a t i o n s .A l lt h e
studies compared psychotherapy to a care-as-usual
group. All psychological treatments in the experimental
groups consisted of integrative psychotherapy, of which
non-directive supportive therapy (SUP) and cognitive
behavior therapy (CBT) were the dominant components.
There were five studies in which the psychotherapy was
delivered in individual face-to-face format and eight stu-
dies in which the psychotherapy was delivered in mixed
format incorporating both individualized and group
treatments (Table 1). Finally, the depression score at
post-test was assessed by clinicians in two studies, while
that of the other eleven studies was assessed by self-
report questionnaires (e.g., Self-rating Depression Scale).
Quality assessment
The quality of the studies was not optimal. None of the
thirteen studies reported whether allocation to condi-
tions was conducted by an independent party. In eleven
studies self-rating scales were used (and so blinding of
assessors was not relevant), while two studies did not
provide information whether assessors were blinded.
Finally, the absence of drop-out in all included studies
indicated a completeness of follow-up data.
Effects of psychological treatments on depression
compared to care-as-usual
Thirteen studies reported post-test effects of psychological
treatment on depressive symptoms compared with care-
as-usual control group, with a total of 816 respondents
(413 people in the experimental condition, and 403 people
in the control condition). The random effects model
showed an overall effect size of d = 0.96 (95% CI = 0.63-
1.28; p< 0.001). However, the homogeneity analysis of the
effect sizes (Q =5 8 . 5 2 ,p < 0.001; I
2 = 79.49%) showed that
there was considerable heterogeneity. After removal of
one outlier whose effect size fell out of 3 SD from the
mean effect size [39], the remaining studies included a
total of 758 respondents with 384 people in the experi-
mental condition, and 374 people in the control condition.
The random effects model analysis showed an overall
effect size of d = 0.80 (95% CI = 0.60-0.99; p < 0.001) and
low to moderate heterogeneity (Q = 18.66, n.s.; I
2 =
41.04%). The effect sizes and 95% confidence intervals of
the individual contrast groups are plotted in Figure 2.
These analyses indicate that psychological treatments have
large effects on depressive symptoms in elderly inpatients
with significant medical comorbidity.
Effects of psychological treatments on somatic outcomes
There were nine studies in which the treatment effects
on medical comorbidity were reported (Table 1). After
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may be affected by patients’ bias or in which it was diffi-
cult to characterize whether the treatment of medical
comorbidity was successful or not, five studies with 305
respondents (156 people in the experimental groups,
and 149 people in the control groups) were included in
the analysis of the effects of psychological treatments on
somatic outcomes. In these five studies, it was indicated
whether the treatment was very effective, effective,
barely effective or not effective according to clinically
objective indicators (e.g. electrocardiograph examination
or blood glucose levels). We dichotomized these out-
comes was effective (very effective, effective) or not
effective (barely effective, not effective), and calculated
the relative risk (RR) of the intervention of being effec-
tive or not, compared to the control condition. The
pooled RRs were also calculated with the random effects
model. The results showed a RR of 1.52 (95% CI = 1.25-
1.85; p < 0.001), with low heterogeneity (Q =5 . 0 1 ,n.s.;
I
2 = 20.17%). The effect sizes and 95% confidence
intervals of the individual contrast groups are plotted in
Figure 3. The result indicates that psychological treat-
ments have moderate effects on medical comorbidity of
depressed elderly inpatients.
Publication bias
Visual inspection of the funnel plot indicated some pub-
lication bias. Duvall and Tweedie trim and fill procedure
resulted in an effect size of d = 0.88 (95% CI = 0.68-
1.09; number of imputed studies: 2), which suggesting
that the results of the study were not significantly
altered after adjusting for the publication bias.
Discussion
In the present study, we analyzed the effects of psycho-
logical treatments on depressed Chinese elderly inpati-
ents with significant medical comorbidity. Psychological
treatments showed large effects on their depressive
symptoms, which is similar to the findings of psycholo-
gical treatments for depression in older adults in the
Cardiovascular (n = 5) 
Included (n = 13) 
Prostatic hyperplasia (n = 2) 
Stroke (n =3) 
Diabetes mellitus (n = 1) 
Leukemia (n = 1)  Other (n = 1) 
Records identified through database searching 
(n = 525) 
Excluded based on title or 
      A b s t r a c t   ( n   =   4 0 4 )  
Full-text retrieved (n = 121) 
Excluded: No RCT (n = 33) 
Pharmacotherapy trials (n = 26) 
Not exclusively 
psychotherapy (n = 25) 
Other reasons (n = 24) 
Figure 1 Selection of studies for the review.
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Author
& Year
Comorbidity Age Definition of
depression
Conditions N Nse Frm Depression
measures
Clinical index
Du, 2007 Atrial
fibrillation
60-80;
M=
66.0
Other definition
(MSDS = 55.25)
1.CBT + SUP + Health
education + Relaxation+
Music therapy
30 10 Ind SDS The number different curative
effects
2. Care-as-usual 30
Hu &
Gui,
2007
Leukemia 60-82 Other definition
(SDS > 40; MSDS =
53.77)
1. SUP + Teleotherapeutics 25 - Ind SDS -
2. Care-as-usual 25
Kong &
Li, 2004
Stroke 60-82;
M=
62.7
Clinical diagnosis
(DSM-3-R; HRSD ≥
13; MHRSD = 20.53)
1. CBT+SUP 34 - Mixed HRSD The number different curative
effects
2. Care-as-usual 30
Li, 2007 Somatic
disease
M = 74 Other definition
(SDS > 40; MSDS =
62.22)
1. CT + SUP 27 - Ind SDS -
(-) 2. Care-as-usual 25
Li et al.,
2007
Prostatic
hyperplasia
60-76 Other definition
(MSDS = 54.70)
1. SUP + Relaxation + Health
education + Music therapy
40 - Mixed SDS The number of spastic
bladder; The number of using
anodyne
2. Care-as-usual 40
Liu et al.,
2000
DM 60-79;
M=
63.1
Other definition
(MSCL-90-D = 1.73)
1.CT+ SUP +Health education
+ Relaxation + Music therapy
32 - Mixd SCL-90-D The number of different
curative effects
2. Care-as-usual 32
Meng,
2007
CHD 63-83;
M=
75.2
Other definition
(MSDS = 56.23)
1. SUP + Relaxation therapy
+Music therapy
32 - Mixed SDS SAQ; The number of different
curative effects
2. Care-as-usual 32
Qu, 2002 CHF ≥ 65; M
= 66.5
Other definition
(MSDS = 55.32)
1. CBT + SUP 28 16 Ind SDS The number of different
curative 24 effects
2. Care-as-usual 28
Shu &
Dong,
2008
CHD 65-84 Other definition
(MSDS = 53.15)
1.CBT+ SUP + Relaxation +
Health education +Music
therapy
20 8 Mixed SDS -
2. Care-as-usual 20
Tang et
al., 2008
Stroke 61-85;
M=
65.5
Clinical diagnosis
(CCMD-3, HRSD ≥
17; MHRSD = 22.31)
1. CT + SUP 29 - Mixed HRSD BI; FMA; NFA
2. Care-as-usual 29
Xie &
Jiang,
2005
BPH 60-78;
M=
67.3
Other definition
(MSCL-90-D = 1.68)
1. BT + SUP + Health
education
35 - Mixed SDS SF-36
2. Care-as-usual 30
Zhou et
al., 2008
Hypertension 65-80;
M=
72.7
Other definition
(SDS ≥ 50; MSDS =
53.7)
1.SUP + CT + Relaxation
therapy
50 16 Mixed SDS SBP, DBP
2. Care-as-usual 50
Zhu et
al., 2007
Stroke 60-82;
M=
66.1
Other definition
(MSCL-90-D = 2.13)
1. CT + SUP + Health
education
31 18 Ind SCL-90-D -
2. Care-as-usual 31
Abbreviations: BI-Barthel Index; BPH, benign prostatic hypertrophy; CCMD, Clinical diagnosis according to the Chinese Classification of Mental Disorders; CBT,
cognitive behavior therapy; CHF, chronic heart failure; CHD, coronary heart disease; Clinical index, The measures were used for assessment of effecto f
psychological interventions on significant medical comorbidity; CT, cognitive therapy; DBP, Diastolic blood pressure; DM, diabetes mellitus; Frm, format; HRSD,
Hamilton Depression Scale; Ind, individual format; Mixed, format incorporating both individualized and group treatment; NFA, Neurological function assessment;
Nse, number of sessions; SAQ, Seattle Angina Questionnaire; SBP, Systolic blood pressure; SCL-90-D, Symptom Checklist 90-Depression; SDS, Self-rating
Depression Scale; SF-36, 36-item short-form healthy survey; SUP, Non-directive supportive therapy; the number of different curative effects, the number of
participants whose curative effects of significant medical comorbidity are effective (very effective, effective) or not effective (barely effective, not effective); -, no
report.
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older depressed adults with significant medical comor-
bidity may show lower response to psychological treat-
ments for depression [22], while other revealed that
psychological treatments for late-life depression are
effective among the terminally ill [41]. The present
r e s u l tm a yb ed u et ot h ef o l l o w i n gr e a s o n s .F i r s t ,f r o m
the perspective of life-span development, older adults
still have the ability to acquire new knowledge and skills
and to use them in their daily life [42]. Second, given
that there were high levels of comorbidity in the sam-
ples, which increased the complexity of treatment, the
integrative psychotherapy focusing on different types of
behaviors, problems, or symptoms may be advantageous
[43,44]. All the psychological treatments in the present
s t u d yc o m p r i s ei n t e g r a t i v epsychotherapy, which may
increase the treatment effects. Third, compared to out-
patient samples who may have higher drop-out rates
Study name Statistics for each study Std diff in means and 95% CI
Std diff  Standard  Lower  Upper 
in means error limit limit Z-Value p-Value
Du(2007) 0.648 0.265 0.129 1.167 2.446 0.014
Hu & Gui (2007) 0.768 0.293 0.193 1.342 2.620 0.009
Kong & Li(2004) 1.290 0.275 0.751 1.830 4.688 0.000
Li (2007) 1.246 0.303 0.652 1.841 4.109 0.000
Li et al.(2007) 0.848 0.233 0.390 1.305 3.632 0.000
Liu et al. (2000) 0.180 0.253 -0.315 0.675 0.713 0.476
Meng (2007) 0.579 0.255 0.079 1.079 2.269 0.023
Qu (2002) 0.592 0.273 0.057 1.127 2.167 0.030
Shu & Dong(2008) 0.767 0.328 0.125 1.409 2.341 0.019
Xie & Jiang(2005) 0.764 0.258 0.259 1.269 2.964 0.003
Zhou et al.(2008) 1.282 0.220 0.852 1.713 5.839 0.000
Zhu et al.(2007) 0.579 0.259 0.071 1.088 2.235 0.025
0.795 0.100 0.599 0.990 7.972 0.000
-2.00 -1.00 0.00 1.00 2.00
Favours control Favours therapy
Figure 2 Post-treatment effect sizes of psychological treatment for depressive symptoms in inpatients with significant medical
comorbidity compared to care-as-usual.
Figure 3 Post-treatment effects of psychological treatment for depression in inpatients with significant medical comorbidity on the
somatic treatment, compared to care-as-usual: Relative risk.
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all of the samples in our study were inpatients who had
adequate time and appropriate locations to receive psy-
chological treatments, thus with a reduced risk for treat-
ment drop-out. Recent studies emphasized the issues of
compliance and dropout in treatment research on older
people, and claimed that the drop-out rate served as an
important indicator of therapeutic effectiveness [45].
Therefore, the large treatment effect in the present
study may be due to the absence of drop-out. Fourth,
the psychological treatments were executed by doctors
who are highly respected by patients in Chinese culture,
which may have improved not only compliance but also
motivation for receiving treatment in patients. In addi-
tion, it is very well possible that the inpatients were con-
cerned that it would reduce the quality of care they
receive from their doctors if they refused to participate
in the interventions initiated by their doctors. This is
also reflected by absence of drop-out in all of the stu-
dies. Fifth, having a care-as-usual control group rather
than an active control group (such as other psychother-
apy or pharmacotherapy) may have increased the effect
sizes.
Since depression may influence treatment for signifi-
cant medical comorbidity in patients, the psychological
treatment of depression might improve the functional
health of patients, contributing to an improvement in
their significant medical comorbidity as well. This has
been rarely examined in previous studies [7,46]. Further-
more, there is no meta-analysis to test this issue yet. In
our present study, we found that psychological treat-
ments have moderate effects on medical comorbidity
among Chinese elderly inpatients. For example, psy-
chotherapies could improve somatic function, increase
quality of life and hasten recovery.
The present study has several limitations. First, a rela-
tively small number of studies were used in this meta-
analysis, which means the results should be interpreted
with caution. The low number of studies also limits the
possibility of conducting subgroup analyses to identify
some potential important moderators such as the cate-
gories of significant medical comorbidity, the treatment
formats or treatment intensity that may also affect the
effect sizes. Second, we found that the quality of the
included studies in the present study was not optimal.
For example, many studies did not report whether
assignment to conditions was executed by an indepen-
dent person, or whether blinding of assessors was con-
ducted. Third, because follow-up results after post-test
were not reported, we do not know whether there are
long term effects. Fourth, the psychological treatments
of all studies were integrative, so we could not compare
the effects of different psychotherapies in this special
population. Fifth, all studies were conducted in China,
so whether the present results could be extended to
Western populations needs a more comprehensive
meta-analysis including studies conducted in Western
countries.
Despite these limitations, we firmly conclude that psy-
chological treatments are efficacious for Chinese elderly
inpatients with significant medical comorbidity. Though
the point was concluded based upon Chinese samples, it
may still have important implications. First, there is a
high comorbidity rate in older adults’ depression and
physical diseases. Second, a large number of inpatients
with significant medical comorbidity who suffer depres-
sion go undetected and untreated [7]. And third, older
adults prefer receiving psychotherapy to taking antide-
pressant medication due to the adverse effects of antide-
pressants [47]. Therefore, general practitioners should
pay more attention to psychological treatments of the
depressive symptoms in older inpatients with significant
medical comorbidity in medical settings, as psychologi-
cal treatments are not only effective for reducing
depressive symptoms, but also efficacious for alleviating
somatic symptoms. Another important and helpful
advice from the present research is that the therapists
should also pay more attention to improving the
patients’ motivation for psychological treatments in
order to reduce the drop-out rate in this population. In
addition, this study also suggested that the psychothera-
pies widely used in Western countries are also effica-
cious in Eastern culture context.
Conclusions
We conclude that psychological treatments of depressive
symptoms could mitigate both depressive symptoms and
somatic symptoms in Chinese elderly inpatients with
significant medical comorbidity.
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